StockData
Aardvark Therapeutics, Inc. logo

Aardvark Therapeutics, Inc. (AARD) stock

AARDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.26−0.07 (-5.26%)

Close on Nov 16, 2026Market cap $27.57MP/E –Yield –

Aardvark Therapeutics EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

No ev/ebitda figures for Aardvark Therapeutics

Aardvark Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Aardvark Therapeutics figures

See a number that looks wrong?